Task: Answer the multiple choice question.
Question: Which compound exhibits a -23.155% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] O=C(CSc1nccn1Cc1ccccc1)Nc1nccs1
[b] CCOP(=O)(OCC)C(NC(=O)CN1C(=O)c2ccccc2S1(=O)=O)C(Cl)(Cl)Cl
[c] O=C(CCc1nnc2ccc(NCc3ccco3)nn12)Nc1cc(F)ccc1F
Answer: c. O=C(CCc1nnc2ccc(NCc3ccco3)nn12)Nc1cc(F)ccc1F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCc1nnc2ccc(NCc3ccco3)nn12)Nc1cc(F)ccc1F
O=C(CCc1nnc2ccc(NCc3ccco3)nn12)Nc1cc(F)ccc1F
N-(2,5-difluorophenyl)-3-[6-(furan-2-ylmethylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanamide